We are delighted to present a panel discussion under the auspices of the German Embassy in Washington, D.C., with Professor Dr. Lothar Wieler, President of the German Robert Koch Institute, Loyce Pace, Global Affairs Director at the US Department of Health and Human Services, and Dr. Stefan Oschmann, CEO of Merck KGaA Darmstadt and CEO of Merck KGaA Darmstadt and Richard Moscicki, M.D., Chief Medical Officer and Executive Vice President of Science and Regulatory Advocacy at PhRMA.
The event will be opened by Dr. Emily Haber, German Ambassador to the United States, and moderated by Professor Dr. Katharina Janus, Professor of Health Policy and Management at Columbia University.
It has been a year since the initial lockdowns across the world, including in Germany and in the U.S. Pandemic management and public health responses have differed greatly from country to country. Even though vaccines have been developed and manufactured in record time, neither Germany nor the U.S. have been able to move back to normalcy – yet. This panel will present the perspectives of the heads and leading experts of public health agencies and pharmaceutical companies on both sides of the Atlantic.
This event is part of a series jointly organized by the German Consulates in Boston and San Francisco together with the German American Business Council in Boston, and the German American Business Association in Northern California.